Skip to main content

Ovarian Cancer

Featured Article
Researchers have identified non-BRCA predisposition genes for breast and ovarian cancer using whole-exome sequencing and gene-phenotype associations. 
According to a new study in JAMA, medically underserved Medicare beneficiaries with breast or ovarian cancer rarely receive BRCA tests, which often help with health-related decision-making.

Interactive Features

Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight…
Back to Top